医学
肺炎克雷伯菌
指南
荟萃分析
抗药性
多重耐药
公共卫生
内科学
环境卫生
重症监护医学
微生物学
生物
病理
生物化学
基因
大肠杆菌
作者
Md. Mudassar Iqbal Lodhi,Surendra Lakshminarayana,Aaftab G.P
标识
DOI:10.18231/j.ijmmtd.2024.004
摘要
The continuous rising of hospital acquired Multi Drug resistant creates an alarming condition in public health worldwide. Objective of this study is to identify quantitative analysis of hospital acquired Multi-Drug resistant in India. Data were collected from Pub Med and Google scholar specific study of India to identify prevalence of Multi-drug resistant nosocomial starting from 2011 to 2023. Literature review were collected and analysed through Preferred reporting Items for Systematic Reviews and meta-analysis (PRISMA) guideline and SPSS- 25 software used for Data analysis. Meta-analysis report reveals that prevalence of multi-drug resistant among hospital acquired is 34.37 % and pooled prevalence rate of hospital acquired multi drug resistant infection found at 2 % (97.5 % CI, 2.5) with p-value is 0.01. Genotypic analysis reveals bla gene identified most among the studied samples. Prevalence of ESBL, MDR associated with nosocomial infections estimated and correlated with mortality and death ratio as well as antibiotic susceptibility tests pattern was analysed in India which shows continuous rising number of MDR and ESBL especially hospital acquired infection. A finding of this study is indicating alarming situation of public health and it should control through interdisciplinary one health approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI